Strategies for tumor immune escape
Piemonti, L.; Zerbi, A.; Di Carlo, V.
Drugs of Today 39(9): 701-724
2003
ISSN/ISBN: 1699-3993 PMID: 14586485 Document Number: 553326
The interactions between the immune system and malignant cells play an important role in tumorigenesis. Evidence that tumors are immunogenic continues to accumulate. Although they frequently express antigens in a form recognizable by the host immune system, tumors commonly "escape" the immune response. Tumors may therefore progress by evolving variants that can evade immune responses or by developing other strategies to avoid immune control. The purpose of this review is to evaluate the current status of knowledge concerning these different tumor-escape strategies.
Document emailed within 1 workday
Related Documents
Hyman, R. 1974: Genetic alterations in tumor cells resulting in their escape from the immune response Cancer ChemoTherapy Reports 58(4): 431-439Wang, W.-X.; Dai, K.; Hong, L.; Cai, T.; Tang, L. 2014: The strategies of endosomal escape for intracellular gene delivery Yao Xue Xue Bao 49(8): 1111-1116
Coggin, J.H.; Ambrose, K.R.; Dierlam, P.J.; Anderson, N.G. 1974: Proposed mechanisms by which autochthonous neoplasms escape immune rejection Cancer Research 34(8): 2092-2101
Zhu, Q.; Deng, C. 2002: The role of Fas/Fas ligand in tumorgenesis, immune escape, and counterattack in colonic cancer Zhonghua Nei Ke Za Zhi 41(6): 378-380
Engelmann, I.; Bauer, G. 2000: How can tumor cells escape intercellular induction of apoptosis? Anticancer Research 20(4): 2297-2306
Alexander, P. 1974: Escape from immune destruction by the host through shedding of surface antigens: is this a characteristic shared by malignant and embryonic cells? Cancer Research 34(8): 2077-2082
Yutoku, M.; Fuji, H.; Grossberg, A.L.; Pressman, D. 1975: An experimental model for evaluation of factors in tumor escape from immunological attack Cancer Research 35(3): 734-739
Rousseau, C.M.; Daniels, M.G.; Carlson, J.M.; Kadie, C.; Crawford, H.; Prendergast, A.; Matthews, P.; Payne, R.; Rolland, M.; Raugi, D.N.; Maust, B.S.; Learn, G.H.; Nickle, D.C.; Coovadia, H.; Ndung'u, T.; Frahm, N.; Brander, C.; Walker, B.D.; Goulder, P.J.R.; Bhattacharya, T.; Heckerman, D.E.; Korber, B.T.; Mullins, J.I. 2008: HLA class I-driven evolution of human immunodeficiency virus type 1 subtype c proteome: immune escape and viral load Journal of Virology 82(13): 6434-6446
Hoshino, T.; Jiang, Y.Z.; Dunn, D.; Paul, D.; Qazilbash, M.; Cowan, K.; Wang, J.; Barrett, J.; Liu, J. 1998: Transfection of interleukin-12 cDNAs into tumor cells induces cytotoxic immune responses against native tumor: implications for tumor vaccination Cancer Gene Therapy 5(3): 150-157
Elnemr, A.; Ohta, T.; Yachie, A.; Kayahara, M.; Kitagawa, H.; Ninomiya, I.; Fushida, S.; Fujimura, T.; Nishimura, G.; Shimizu, K.; Miwa, K. 2001: Human pancreatic cancer cells express non-functional Fas receptors and counterattack lymphocytes by expressing Fas ligand; a potential mechanism for immune escape International Journal of Oncology 18(1): 33-39
Glancy, D.Luke.; Chen, A. 2013: ECG of the month. Electrocardiogram in an attempted suicide. Sinus bradycardia with an atrial escape complex, followed by a junctional escape rhythm with isorhythmic atrioventricular dissociation; voltage criteria for left ventricular hypertrophy Journal of the Louisiana State Medical Society: official organ of the Louisiana State Medical Society 165(3): 166-167
Fujimoto, S.; Greene, M.I.; Sehon, A.H. 1976: Regulation of the immune response to tumor antigens. II. the nature of immunosuppressor cells in tumor-bearing hosts Journal of Immunology 116(3): 800-806
Suzuki, Y.; Chen, L.P.; Liu, C.M.; Morita, T.; Wheelock, E.F. 1989: Immune regulation of the L5178Y murine tumor-dormant state: induction of cell- and soluble factor-mediated inhibition of tumor cell growth by tumor necrosis factor and gamma-interferon Cancer Research 49(8): 2028-2033
Carter, R.H.; Drebin, J.A.; Schatten, S.; Perry, L.L.; Greene, M.I. 1983: Regulation of the immune response to tumor antigens. IX. in vitro Lyt-1+2- cell proliferative responses to cellbound or subcellular tumor antigen Journal of Immunology 130(2): 997-1002
Mizushima, Y.; Sendo, F.; Miyake, T.; Kobayashi, H. 1981: Augmentation of specific cell-mediated immune responses to tumor cells in tumor-bearing rats pretreated wih the antileukemia drug busulfan Journal of the National Cancer Institute 66(4): 659-665
Rossowska, J.; Pajtasz-Piasecka, E.; Szyda, A.; Zietara, N.; Duś, D. 2007: Tissue localization of tumor antigen-loaded mouse dendritic cells applied as an anti-tumor vaccine and their influence on immune response Folia Histochemica et Cytobiologica 45(4): 349-355
Nadler, L.M. 1999: Future strategies toward the cure of indolent B-cell malignancies. Immune recognition and antiself Seminars in Hematology 36(4 Suppl 5: 9-11
Perry, L.L.; Benacerraf, B.; Greene, M.I. 1978: Regulation of the immune response to tumor antigen. IV. Tumor antigen-specific suppressor factor(s) bear I-J determinants and induce suppressor T cells in vivo Journal of Immunology 121(6): 2144-2147
King, W.J.; Tomita, J.T.; Dowell, B.L.; Delfert, D.M. 1990: Strategies for heterogeneous enzyme immunoassays for tumor markers Immunology Series 53: 83-93
Sotomayor, E.M.; Fu, Y.X.; Lopez-Cepero, M.; Herbert, L.; Jimenez, J.J.; Albarracin, C.; Lopez, D.M. 1991: Role of tumor-derived cytokines on the immune system of mice bearing a mammary adenocarcinoma. II. Down-regulation of macrophage-mediated cytotoxicity by tumor-derived granulocyte-macrophage colony-stimulating factor Journal of Immunology 147(8): 2816-2823